357 related articles for article (PubMed ID: 11949640)
1. Lower specificity of occult-blood test on stool collected by digital rectal examination.
Zhang B; Nakama H; Fattah AS; Kamijo N
Hepatogastroenterology; 2002; 49(43):165-7. PubMed ID: 11949640
[TBL] [Abstract][Full Text] [Related]
2. Digital rectal fecal occult blood screening during gynecologic examination.
Willis FL; Fanning J
Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic yield of a positive fecal occult blood test found on digital rectal examination. Does the finger count?
Eisner MS; Lewis JH
Arch Intern Med; 1991 Nov; 151(11):2180-4. PubMed ID: 1953220
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
Nakama H; Kamijo N
Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
[TBL] [Abstract][Full Text] [Related]
5. Digital fecal occult blood testing in the ambulatory urology clinic.
Goetzl MA; Outman JE; Griebling TL; Holzbeierlein JM; Weigel JW; Thrasher JB
J Am Coll Surg; 2008 Jan; 206(1):144-7. PubMed ID: 18155580
[TBL] [Abstract][Full Text] [Related]
6. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia.
Nakama H; Yamamoto M; Kamijo N; Li T; Wei N; Fattah AS; Zhang B
Hepatogastroenterology; 1999; 46(25):228-31. PubMed ID: 10228797
[TBL] [Abstract][Full Text] [Related]
7. Comparison of predictive value for colorectal cancer in subjects with and without rectal bleeding.
Nakama H; Kayano T; Katsuura T; Kamigaito T; Shimada S; Nishikawa N; Yoshii S; Kamijo N
Hepatogastroenterology; 1999; 46(27):1730-2. PubMed ID: 10430332
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
Yamamoto M; Nakama H
Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
[TBL] [Abstract][Full Text] [Related]
9. A pilot study evaluating two alternate methods of stool collection for the fecal occult blood test.
Greenwald B
Medsurg Nurs; 2006 Apr; 15(2):89-94. PubMed ID: 16700247
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps.
Nakama H; Fattah A; Zhang B; Uehara Y; Wang C
Hepatogastroenterology; 2000; 47(32):386-9. PubMed ID: 10791196
[TBL] [Abstract][Full Text] [Related]
11. Colorectal adenomatous polyps detected by immunochemical occult blood screening.
Fattah AS; Nakama H; Kamijo N; Fujimori K; Zhang B
Hepatogastroenterology; 1998; 45(21):712-6. PubMed ID: 9684121
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.
Limburg PJ; Devens ME; Harrington JJ; Diehl NN; Mahoney DW; Ahlquist DA
Am J Gastroenterol; 2003 Oct; 98(10):2299-305. PubMed ID: 14572583
[TBL] [Abstract][Full Text] [Related]
13. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
14. A comparison of three stool tests for colorectal cancer screening.
Greenwald B
Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity of several immunochemical tests for colorectal cancer.
Nakama H; Kamijo N; Miyata K; Abdul Fattah AS; Zhang B; Uehara Y
Hepatogastroenterology; 1998; 45(23):1579-82. PubMed ID: 9840108
[TBL] [Abstract][Full Text] [Related]
16. Clinico-pathological features of colorectal adenomatous polyps with negative results on immunochemical fecal occult blood test.
Abdul Fattah AS; Nakama H; Kamijo N
Eur J Med Res; 1997 Aug; 2(8):361-4. PubMed ID: 9262491
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of calgranulin B in stools from the patients with colorectal cancer.
Yoo BC; Shin YK; Lim SB; Hong SH; Jeong SY; Park JG
Dis Colon Rectum; 2008 Nov; 51(11):1703-9. PubMed ID: 18584251
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of colorectal cancer that produce positive immunochemical occult blood test results on stool obtained by digital rectal examination.
Nakama H; Zhang B; Fattah AA; Kamijo N; Zhang X
Can J Gastroenterol; 2001 Apr; 15(4):227-30. PubMed ID: 11331923
[TBL] [Abstract][Full Text] [Related]
19. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
20. [Detection of protein p53 in the stool of patients with colorectal cancer].
Jaïs P; Kapel N; Chosidow D; Rupaire N; Rougier P; Lasser P; Mignon M; Lewin MJ; Gobert JG
Gastroenterol Clin Biol; 1997; 21(10):754-9. PubMed ID: 9587516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
